CD274 and adenocarcinoma: The multivariate analysis identified positive PD-L1 status (p = 0.007) and low tumor stage (p = 0.008) as independent prognostic factors for increased survival of patients with adenocarcinoma who received adjuvant chemotherapy (Table 3).